Home Business Covid-19 Vaccine Maker Blames Problems on Producing Two Different Shots

Covid-19 Vaccine Maker Blames Problems on Producing Two Different Shots

by Bioreports
36 views
covid-19-vaccine-maker-blames-problems-on-producing-two-different-shots

Emergent BioSolutions Inc. blamed some of the problems at its Baltimore drug plant on having to produce two Covid-19 vaccines at large scale, which the company said strained the capacity of its equipment.

Emergent, a contract drug manufacturer, described some of the problems and its plan to fix them in a letter to the U.S. Food and Drug Administration, responding to the agency’s finding of various deficiencies during an April inspection.

A subcommittee of the U.S. House Committee on Oversight and Reform released the April 30 letter on Wednesday, ahead of a hearing by the panel about Emergent.

Emergent was producing a bulk key vaccine ingredient for Johnson & Johnson ’s Covid-19 vaccine, but a mishap led to the contamination of material that could have yielded up to 15 million doses during January and February.

The contamination came from viral material similar to what was used in the production of AstraZeneca PLC’s Covid-19 vaccine at the same plant, according to a memo from the Democratic staff of the House committee to members.

You may also like

Leave a Comment